Review
Published on 07 Oct 2024
Clonal evolution: a landmark of MPN evolution
Frontiers in Hematology
doi 10.3389/frhem.2024.1473920
- 568 views
Volumes
107 Publications
Volume 3 - 2024
Review
Published on 27 Sep 2024
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
Frontiers in Hematology
doi 10.3389/frhem.2024.1468952
- 1,145 views
Review
Published on 25 Sep 2024
Dissecting dormancy and quiescence in hematopoietic stem cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1401713
- 415 views
Original Research
Published on 11 Sep 2024
Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
- 371 views
Editorial
Published on 29 Aug 2024
Editorial: Rising stars in hematopoiesis and stem cells 2023
Frontiers in Hematology
doi 10.3389/frhem.2024.1477997
- 282 views
Perspective
Published on 27 Aug 2024
Sickle cell disease: a comparative perspective on global and national initiatives
Frontiers in Hematology
doi 10.3389/frhem.2024.1457158
- 656 views
Study Protocol
Accepted on 20 Aug 2024
Comparison of 6 cycles of isatuximab with lenalidomide, bortezomib and dexamethasone (I-VRd) versus 3 cycles of I-VRd followed by one cycle of high-dose melphalan in newly diagnosed low-risk multiple myeloma. Protocol for a multicenter, prospective, randomized, phase II clinical trial (ELIAS-Trial)
Frontiers in Hematology
doi 10.3389/frhem.2024.1436845
- 116 views
Editorial
Published on 14 Aug 2024
Editorial: Glycobiology in hematology: a promising avenue for cancer diagnostics and therapeutics
Frontiers in Hematology
doi 10.3389/frhem.2024.1465473
- 507 views
Review
Published on 09 Aug 2024
The nexus between Helicobacter pylori infection and anemia—a systematic review
Frontiers in Hematology
doi 10.3389/frhem.2024.1423494
- 696 views
Review
Published on 06 Aug 2024
Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?
Frontiers in Hematology
doi 10.3389/frhem.2024.1407698
- 1,173 views
Community Case Study
Published on 25 Jul 2024
Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study
Frontiers in Hematology
doi 10.3389/frhem.2024.1441070
- 490 views
Mini Review
Published on 22 Jul 2024
Targeting the bone marrow niche, moving towards leukemia eradication
Frontiers in Hematology
doi 10.3389/frhem.2024.1429916
- 732 views
Original Research
Published on 15 Jul 2024
Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States
Frontiers in Hematology
doi 10.3389/frhem.2024.1405311
- 1,556 views
Review
Published on 12 Jul 2024
Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets
Frontiers in Hematology
doi 10.3389/frhem.2024.1419323
- 1,463 views
Case Report
Published on 10 Jul 2024
Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent
Frontiers in Hematology
doi 10.3389/frhem.2024.1413794
- 521 views
Review
Published on 08 Jul 2024
The sweet symphony of N-glycans in myeloid malignancies
Frontiers in Hematology
doi 10.3389/frhem.2024.1415618
- 485 views